What The Medicines for Human Use (Clinical Trials) Regulations 2004 requires
The UK MHRA Good Clinical Practice Regulations 2004 require sponsors and investigators to comply with the principles of Good Clinical Practice, as outlined in Regulation 3, and to obtain authorization for clinical trials, as stated in Regulation 5.
Pillar: Pharmaceuticals & Life Sciences · Authority: Medicines and Healthcare products Regulatory Agency (MHRA) · Version: 1.0.1 · Last updated:
Primary source: https://www.legislation.gov.uk/uksi/2004/1031/contents/made
SHA-256 integrity: 0cc464ddc6cc25c78016ee2df4e571cfdbb42cb7d92f16542f31fb942fd6ee34
Primary Citations — 5 traced to source
- The Medicines for Human Use (Clinical Trials) Regulations 2004, Regulation 3 - Requirements for the conduct of clinical trials
- The Medicines for Human Use (Clinical Trials) Regulations 2004, Regulation 5 - Authorization of clinical trials
+ 3 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/uk-mhra-good-clinical-practice-regulations-2004.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/uk-mhra-good-clinical-practice-regulations-2004.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/uk-mhra-good-clinical-practice-regulations-2004
- Back to registry: Browse all 10,090 compliance nodes